Toggle light / dark theme

Old people can produce as many new brain cells as teenagers

By Helen Thomson

Old age may have its downsides, but losing the ability to grow new brain cells isn’t one: healthy people in their seventies seem to produce just as many new neurons as teenagers.

The discovery overturns a decades-old theory about how our brains age and could provide clues as to how we can keep our minds sharper for longer.

Scientists Discover That Our Brains Can Process the World in 11 Dimensions

Neuroscientists have used a classic branch of maths in a totally new way to peer into the structure of our brains. What they’ve discovered is that the brain is full of multi-dimensional geometrical structures operating in as many as 11 dimensions.

We’re used to thinking of the world from a 3D perspective, so this may sound a bit tricky, but the results of this new study could be the next major step in understanding the fabric of the human brain – the most complex structure we know of.

This latest brain model was produced by a team of researchers from the Blue Brain Project, a Swiss research initiative devoted to building a supercomputer-powered reconstruction of the human brain.

New York Is Dealing With an Old Enemy—Measles

New York is in the midst of an outbreak of measles, a childhood disease that shouldn’t really exist in the U.S. any longer. On Tuesday, NBC News reported, New York health officials said the state has seen more than 100 cases of the vaccine-preventable disease since last September—a tally not seen in decades. The majority of these cases have happened among the unvaccinated.

Measles is a highly infectious disease that can be spread with a simple cough or sneeze. Its flu-like symptoms are usually followed by a distinctive, splotchy red rash that runs down from head to feet. And though most people recover without incident after a week’s time, measles can rarely cause more serious complications like hearing loss, permanent brain damage, and even death. These risks are more likely in the very young; measles can also cause birth problems in children whose mothers contract it while pregnant.

Drug to clear ‘zombie cells’ from body could be first anti-ageing treatment after ’impressive‘ human trial

A drug to fight ageing may finally be on the horizon after the first trial in humans showed ‘impressive’ results.

For many years scientists have known that an accumulation of senescent cells in the body is linked to ageing symptoms such as frailty and arthritis, as well as diseases such as Alzheimer’s and Parkinson’s.

Senescent cells — also known as zombie cells — are not completely dead so are not cleared out by the body, but are too damaged to repair tissue or carry out normal functions. Unable to repair itself or clear out the waste, the body gradually deteriorates.

Your Brain Isn’t a Computer — It’s a Quantum Field

While our choices and beliefs don’t often make sense or fit a pattern on a macro level, at a “quantum” level, they can be predicted with surprising accuracy.


The irrationality of how we think has long plagued psychology. When someone asks us how we are, we usually respond with “fine” or “good.” But if someone followed up about a specific event — “How did you feel about the big meeting with your boss today?” — suddenly, we refine our “good” or “fine” responses on a spectrum from awful to excellent.

In less than a few sentences, we can contradict ourselves: We’re “good” but feel awful about how the meeting went. How then could we be “good” overall? Bias, experience, knowledge, and context all consciously and unconsciously form a confluence that drives every decision we make and emotion we express. Human behavior is not easy to anticipate, and probability theory often fails in its predictions of it.

Enter quantum cognition : A team of researchers has determined that while our choices and beliefs don’t often make sense or fit a pattern on a macro level, at a “quantum” level, they can be predicted with surprising accuracy. In quantum physics, examining a particle’s state changes the state of the particle — so too, the “observation effect” influences how we think about the idea we are considering.

Mental Candy Is Also Unhealthy

We take a somewhat humorous look at the messaging and the comfort stories people tell themselves to distract themselves from seeing why age-related diseases and dying from them is a problem that needs solving.


Here’s what might be considered a paradox: right now, the Facebook page of Death Cafe—a place where you go to talk about death—is a rather lively place, whereas pages about life extension are comparatively rather dead places. This screenshot shows the activity of a Death Cafe post:

There is no doubt that the subscribers of the Death Cafe page are quite engaged, but if the average message that the page aims at conveying is the same as in the text snippet above, then there is no paradox at all. The core of that message is “don’t worry, death is nothing to fear” (which, incidentally, implies you don’t have to engage in any extra effort to prevent death), whereas the core message of a life extension page is, “death is a problem, but hey—with some effort, we can beat it. Maybe.” That’s a bit like a kiosk giving candy away for free right next to another kiosk that first serves you overcooked broccoli and then says that you might get a nice present decades from now, assuming that you work hard enough for it—where do you think most people would flock to? Exactly.

Bottle feeding may play role in whether kids are left-handed

Bottle feeding infants is associated with left-handedness, according to a new study.

The study finds that the prevalence of left-handedness is lower among breastfed infants as compared to bottle-fed infants. The researchers identified this finding in about 60,000 mother-infant pairs and they accounted for known risk factors for handedness.

The results provide further insight into the development of complex brain functions which ultimately determine which side of the batter box the infant likely will choose.

Intraoperative detection of blood vessels with an imaging needle during neurosurgery in humans

Intracranial hemorrhage can be a devastating complication associated with needle biopsies of the brain. Hemorrhage can occur to vessels located adjacent to the biopsy needle as tissue is aspirated into the needle and removed. No intraoperative technology exists to reliably identify blood vessels that are at risk of damage. To address this problem, we developed an “imaging needle” that can visualize nearby blood vessels in real time. The imaging needle contains a miniaturized optical coherence tomography probe that allows differentiation of blood flow and tissue. In 11 patients, we were able to intraoperatively detect blood vessels (diameter, 500 μm) with a sensitivity of 91.2% and a specificity of 97.7%. This is the first reported use of an optical coherence tomography needle probe in human brain in vivo. These results suggest that imaging needles may serve as a valuable tool in a range of neurosurgical needle interventions.

Stereotactic brain biopsies are a minimally invasive procedure used to obtain samples of intracranial tissue for diagnostic purposes, most commonly related to brain tumors. Approximately 80,000 new cases of primary brain tumor are diagnosed, and 14,000 brain biopsies are performed each year in the United States (1, 2). Hemorrhage is the most frequent and devastating complication associated with this procedure. Perioperative hemorrhage is associated with rates of transient and permanent morbidity of 1.7 to 8.5% and 1.4 to 4.8%, respectively, and mortality rates of 0.6 to 2.8% (37).

The standard clinical practice is to identify blood vessels at risk of injury on preoperative imaging, using either contrast-enhanced magnetic resonance imaging (MRI) or x-ray computed tomography. Frameless stereotactic navigation techniques, guided by preoperative imaging, are then used to direct the biopsy needle trajectory to sample the target lesion, while avoiding vasculature or eloquent brain tissue (8).

Immune cells track hard-to-target brain tumours

Two Nature papers show that it is possible to make T cells that target some of the few neoantigens expressed by glioblastomas and that T- cell responses can be boosted in cancers. This News & Views discusses the findings.


Clinical trials reveal that personalized vaccines can boost immune-cell responses to brain tumours that don’t usually respond to immunotherapy. The findings also point to how to improve such treatments. Personalized vaccines boost immune responses targeting brain tumours.